A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

Clinical trial NCT02599779 · COMPLETED

Trial details

NCT number: NCT02599779
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Renal Cell Cancer AJCC V7

Start date: 2016-12-01
Primary completion: 2021-08-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.